BayesMendel: an R Environment for Mendelian Risk Prediction

Several important syndromes are caused by deleterious germline mutations of individual genes. In both clinical and research applications it is useful to evaluate the probability that an individual carries an inherited genetic variant of these genes, and to predict the risk of disease for that individual, using information on his/her family history. Mendelian risk prediction models accomplish these goals by integrating Mendelian principles and state-of-the-art statistical models to describe phenotype/genotype relationships. Here we introduce an R library called BayesMendel that allows implementation of Mendelian models in research and counseling settings. BayesMendel is implemented in an object-oriented structure in the language R and distributed freely as an open source library. In its first release, it includes two major cancer syndromes: the breast-ovarian cancer syndrome and the hereditary non-polyposis colorectal cancer syndrome, along with up-to-date estimates of penetrance and prevalence for the corresponding genes. Input genetic parameters can be easily modified by users. BayesMendel can also serve as a generic tool for genetic epidemiologists to flexibly implement their own Mendelian models for novel syndromes and local subpopulations, without reprogramming complex statistical analyses and prediction tools.

[1]  Giovanni Parmigiani,et al.  Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard. , 2005, Biostatistics.

[2]  M. King,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.

[3]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[4]  Giovanni Parmigiani,et al.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Møller,et al.  MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Euhus Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling , 2001, The breast journal.

[7]  David Valle,et al.  Human disease genes , 2001, Nature.

[8]  N. Carson,et al.  A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center , 2000, Clinical genetics.

[9]  Donald A. Berry,et al.  Genetic Susceptibility and Survival: Application to Breast Cancer , 2000 .

[10]  D. Easton,et al.  Risk models for familial ovarian and breast cancer , 2000, Genetic epidemiology.

[11]  A. de la Chapelle,et al.  Genetic susceptibility to non-polyposis colorectal cancer , 1999, Journal of medical genetics.

[12]  F. Rassool Inherited Susceptibility to Cancer: Clinical, Predictive and Ethical Perspectives , 1999, BMJ.

[13]  C. R. Palmer Encyclopedia of Biostatistics , 1999, BMJ.

[14]  Donald A. Berry,et al.  Modeling Risk of Breast Cancer and Decisions about Genetic Testing , 1999 .

[15]  D. Berry,et al.  Validating Bayesian Prediction Models: a Case Study in Genetic Susceptibility to Breast Cancer , 1999 .

[16]  C. Rubin,et al.  Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions , 1998, Annals of Internal Medicine.

[17]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[18]  B. Weber Update on breast cancer susceptibility genes. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[19]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.

[20]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[21]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[22]  D. Berry,et al.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. , 1997, Journal of the National Cancer Institute.

[23]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[24]  R. Fodde,et al.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. , 1996, Gastroenterology.

[25]  L. Cavalli-Sforza,et al.  Genetic variation and human disease , 1996 .

[26]  K. Offit,et al.  Quantitating familial cancer risk: a resource for clinical oncologists. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .

[28]  Peter Szolovits,et al.  Pedigree Analysis for Genetic Counseling , 1992 .

[29]  M. King,et al.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Elston,et al.  A general model for the genetic analysis of pedigree data. , 1971, Human heredity.

[31]  E. Murphy,et al.  The Application of Bayesian Methods in Genetic Counselling , 1969 .